LPAR5 and psoriasis: Although we did not determine direct effects of LPA itself on psoriasis-like symptoms, our results clearly suggested that LPA5 was a pathogenic factor for psoriasis based on LPA5 upregulation in psoriasis lesions and attenuated psoriasis-like symptoms in IMQ-treated mice by its antagonism.